GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $791,000 | -17.9% | 3,647 | -56.3% | 0.00% | -20.0% |
| Q4 2020 | $963,000 | +8.7% | 8,347 | -8.3% | 0.01% | 0.0% |
| Q3 2020 | $886,000 | -17.4% | 9,105 | +4.2% | 0.01% | -28.6% |
| Q2 2020 | $1,073,000 | +22.8% | 8,741 | -12.4% | 0.01% | 0.0% |
| Q1 2020 | $874,000 | -33.1% | 9,977 | -20.2% | 0.01% | -22.2% |
| Q4 2019 | $1,307,000 | +26.0% | 12,497 | +38.6% | 0.01% | +12.5% |
| Q3 2019 | $1,037,000 | -41.8% | 9,014 | -12.8% | 0.01% | -42.9% |
| Q2 2019 | $1,781,000 | +87.3% | 10,333 | +83.1% | 0.01% | +75.0% |
| Q1 2019 | $951,000 | +303.0% | 5,642 | +233.6% | 0.01% | +300.0% |
| Q2 2018 | $236,000 | +5.4% | 1,691 | -0.2% | 0.00% | 0.0% |
| Q4 2017 | $224,000 | -65.5% | 1,694 | -73.5% | 0.00% | -71.4% |
| Q3 2017 | $650,000 | – | 6,401 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |